Horizon Pharma USA Overview
- Year Founded
-
2005
- Status
-
Acquired/Merged
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$30M
Horizon Pharma USA General Information
Description
Developer of prescription drugs for mild to moderate pain relief and arthritis. The company's product candidates include a proprietary fixed dose combination formulation of NSAID and ibuprofen; and a combination oral drug product consisting of naproxen and famotidine.
Contact Information
Corporate Office
- 1033 Skokie Boulevard
- Suite 355
- Northbrook, IL 60062
- United States
Corporate Office
- 1033 Skokie Boulevard
- Suite 355
- Northbrook, IL 60062
- United States
Horizon Pharma USA Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC | 18-Mar-2010 | $30M | Completed | Generating Revenue | ||
| 6. Later Stage VC (Series D) | 18-Feb-2010 | Completed | Generating Revenue | |||
| 5. Early Stage VC | 01-Dec-2009 | Completed | Startup | |||
| 4. Debt - General | 31-Dec-2007 | Completed | ||||
| 3. Later Stage VC (Series C) | 23-Jul-2007 | Completed | Startup | |||
| 2. Early Stage VC (Series B) | 01-Nov-2006 | $15M | $21M | Completed | Startup | |
| 1. Early Stage VC (Series A) | 01-Oct-2005 | $6.05M | $6.05M | Completed | Startup |
Horizon Pharma USA Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series D | ||||||||
| Series Special | ||||||||
| Series C | ||||||||
| Series B | 1,482,213 | $0.000100 | $0.81 | $10.12 | $10.12 | 1x | $10.12 | 9.01% |
| Series A | 1,192,118 | $0.000100 | $0.41 | $5.08 | $5.08 | 1x | $5.08 | 7.24% |
Horizon Pharma USA Former Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| EW Healthcare Partners | Growth/Expansion | Minority | ||
| Pequot Ventures | Venture Capital | Minority | ||
| Scale Venture Partners | Venture Capital | Minority | ||
| Sutter Hill Ventures | Venture Capital | Minority |
Horizon Pharma USA FAQs
-
When was Horizon Pharma USA founded?
Horizon Pharma USA was founded in 2005.
-
Where is Horizon Pharma USA headquartered?
Horizon Pharma USA is headquartered in Northbrook, IL.
-
What industry is Horizon Pharma USA in?
Horizon Pharma USA’s primary industry is Pharmaceuticals.
-
Is Horizon Pharma USA a private or public company?
Horizon Pharma USA is a Private company.
-
What is Horizon Pharma USA’s current revenue?
The current revenue for Horizon Pharma USA is .
-
How much funding has Horizon Pharma USA raised over time?
Horizon Pharma USA has raised $129M.
-
Who are Horizon Pharma USA’s investors?
EW Healthcare Partners, Pequot Ventures, Scale Venture Partners, and Sutter Hill Ventures have invested in Horizon Pharma USA.
-
When was Horizon Pharma USA acquired?
Horizon Pharma USA was acquired on 18-Mar-2010.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process